Differential and Converging Molecular Mechanisms of Antidepressants' Action in the Hippocampal Dentate Gyrus

Neuropsychopharmacology

Volumn 40, Issue 2, 2015, Pages 338-349

  Patrício, Patrícia ^a,b   Mateus Pinheiro, António ^a,b   Irmler, Martin ^c   Alves, Nuno D ^a,b   Machado Santos, Ana R ^a,b   Morais, Mónica ^a,b   Correia, Joana S ^a,b   Korostynski, Michal ^d   Piechota, Marcin ^d   Stoffel, Rainer ^e   Beckers, Johannes ^c,f   Bessa, João M ^a,b   Almeida, Osborne Fx ^e   Sousa, Nuno ^a,b   Pinto, Luísa ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d INSTITUTE OF PHARMACOLOGY   (Poland)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; AGOMELATINE; ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; THIAZEPINE DERIVATIVE; TIANEPTINE;

ANIMAL; CHRONIC DISEASE; COMPARATIVE STUDY; DENTATE GYRUS; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; MALE; MENTAL STRESS; METABOLISM; NERVE CELL; PATHOLOGY; RANDOMIZATION; UNCERTAINTY; WISTAR RAT;

ACETAMIDES; ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DENTATE GYRUS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FLUOXETINE; GENE EXPRESSION; IMIPRAMINE; MALE; NEURONS; RANDOM ALLOCATION; RATS, WISTAR; STRESS, PSYCHOLOGICAL; THIAZEPINES; UNCERTAINTY;

EID: 84929660426     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.176     Document Type: Article

References (59)

1. Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ et al (2012). Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry 17 : 49-61.
2. Banasr M, Soumier A, Hery M, Mocaer E, Daszuta A (2006). Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 59: 1087-1096.
3. Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O (2010). miR-16 targets the serotonin transporter: A new facet for adaptive responses to antidepressants. Science 329: 1537-1541.
4. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al (2009a ). The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatr y 14: 764-773, 739.
5. Bessa JM, Mesquita AR, Oliveira M, Pego JM, Cerqueira JJ, Palha JA et al (2009b ). A trans-dimensional approach to the behavioral aspects of depression. Front Behav Neurosci 3: 1.
6. Bessa JM, Morais M, Marques F, Pinto L, Palha JA, Almeida OF et al (2013). Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens. Transl Psychiatry 3: E266.
7. Blier P, Blondeau C (2011). Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder. J Affect Disord 128(Suppl 1): S3-S10.
8. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS et al (2008). A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding b rain development and function. J Neurosci 28: 264-278.
9. Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP et al (2007). Region-specific transcriptional changes following the three antidepr essant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 12: 167-189.
10. Cryan JF, Slattery DA (2007). Animal models of mood disorders: Recent developments. Curr Opin Psychiatry 20: 1-7.
11. Datson NA, Speksnijder N, Mayer JL, Steenbergen PJ, Korobko O, Goeman J et al (2012). The transcriptional response to chronic stress and glucocorticoid receptor blockade in the hippo campal dentate gyrus. Hippocampus 22: 359-371.
12. Drigues N, Poltyrev T, Bejar C, Weinstock M, Youdim MB (2003). cDNA gene expression profile of rat hippocampus after chronic treatment with antidepress ant drugs. J Neural Transm 110: 1413-1436.
13. Duric V, Banasr M, Licznerski P, Schmidt HD, Stockmeier CA, Simen AA et al (2010). A negative regulator of MAP kinase causes depressive behavior. Nat Med 16: 1328-1332.
14. Encinas JM, Vaahtokari A, Enikolopov G (2006). Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci USA 103: 8233-8238.
15. Felice D, O'Leary OF, Pizzo RC, Cryan JF (2012). Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: Relevance to antidepressant action. Neuropharmacology 63: 1 380-1388.
16. Gaska M, Kusmider M, Solich J, Faron-Gorecka A, Krawczyk MJ, Kulakowski K et al (2012). Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals tem poral dynamics in response to antidepressant drugs at the transcriptome level. Psychopharmacology (Berl) 223: 281-297.
17. Hansen KF, Obrietan K (2013). MicroRNA as therapeutic targets for treatment of depression. Neuropsychiatr Dis Treat 9: 1011-1021.
18. Hill MN, Hellemans KG, Verma P, Gorzalka BB, Weinberg J (2012). Neurobiology of chronic mild stress: Parallels to major depression. Neurosci Biobehav Rev 36: 2085-2117.
19. Huang CY, Tan TH (2012). DUSPs, to MAP kinases and beyond. Cell Biosci 2: 24.
20. Kheirbek MA, Drew LJ, Burghardt NS, Costantini DO, Tannenholz L, Ahmari SE et al ( 2013). Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron 77: 955-968.
21. Kohen R, Dobra A, Tracy JH, Haugen E (2014). Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl Psychiatry 4: E366.
22. Korostynski M, Piechota M, Dzbek J, Mlynarski W, Szklarczyk K, Ziolkowska B et al (2013). Novel drug-regulate d transcriptional networks in brain reveal pharmacological properties of psychotropic drugs. BMC Genomics 14: 606.
23. Landgrebe J, Welzl G, Metz T, Van Gaalen MM, Ropers H, Wurst W et al (2002). Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling. J Psychiatr Res 36: 119-129.
24. Lang UE Borgwardt S 2013 Molecular mechanisms of depression: Perspectives on new treatment strategies Cell Physiol Biochem 31 761-777.
25. Lee JH, Ko E, Kim YE, Min JY, Liu J, Kim Y et al (2010). Gene expression profile analysis of genes in rat hippocampus from antidepr essant treated rats using DNA microarray. BMC Neurosci 11: 152.
26. Lewis BP, Burge CB, Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
27. Li X, Frye MA, Shelton RC (2012). Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology 37: 77-101.
28. Lisowski P, Juszczak GR, Goscik J, Stankiewicz AM, Wieczorek M, Zwierzchowski L et al (2013). Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice. BMC Neurosci 14: 144.
29. Lucassen PJ, Pruessner J, Sousa N, Almeida OF, Van Dam AM, Rajkowska G et al (2014). Neuropathology of stress. Acta Neuropathol 127: 109-135.
30. Malki K, Lourdusamy A, Binder E, Paya-Cano J, Sluyter F, Craig I et al (2012). Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of De pression. Pharmacogenet Genomics 22: 765-776.
31. Manosso LM, Neis VB, Moretti M, Daufenbach JF, Freitas AE, Colla AR et al (2013). Antidepressant-like effect of alpha-tocopherol in a mouse model of depressive-like behavior induced by TNFalpha. Prog Neuropsychopharmacol Biol Psychiatry 46: 48-57.
32. Mateus-Pinheiro A, Patricio P, Alves ND, Machado-Santos AR, Morais M, Bessa JM et al (2014). T he Sweet Drive Test: Refining phenotypic characterization of anhedonic behavior in rodents. Front Behav Neurosci 8: 74.
33. Mateus-Pinheiro A, Patricio P, Bessa JM, Sousa N, Pinto L (2013a). Cell genesis an d dendritic plasticity: A neuroplastic pas De deux in the onset and remission from depression. Mol Psychiatry 18: 748-750.
34. Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, AlvesND,Monteiro S et al (2013b). Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 3: E210.
35. McClung CA, Nestler EJ (2008). Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33: 3-17.
36. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P et al (2010). The neurobiological properties of tianeptine (Stablon): From monoamine hypothesis to glutamatergic modulation. Mol Psychiatry 15: 237-249.
37. Nakatani N, Aburatani H, Nishimura K, Semba J, Yoshikawa T (2004). Comprehensive expression analysis of a rat depression model. Pharmacogenomics J 4: 114-126.
38. Negishi M, Katoh H (2005). Rho family GTPases and dendrite plasticity. Neuroscientist 11: 187-191.
39. O'Connor RM, Grenham S, Dinan TG, Cryan JF (2013). micro-RNAs as novel antidepressant targets: Converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int J Neuropsychopharmacol 16: 1885-1892.
40. O'Leary OF, O'Connor RM, Cryan JF (2012). Lithium-induced effects on adult hippocampal neurogenesis are topographically segregated along the dorso-ventral axis of stressed mice. Neuropharmacology 62: 247-255.
41. Olivier P, Fontaine RH, Loron G, Van Steenwinckel J, Biran V, Massonneau V et al (2009). Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLos One 4: E7128.
42. Pinto V, Costa JC, Morgado P, Mota C, Miranda A, Bravo FV et al (2014). Differential impact of chronic stress along the hippocampal dorsal-ventra l axis. Brain Struct Funct, (e-pub ahead of print 6 February 2014; doi:10.1007/s00429-014-0713-0
43. Pittenger C, Duman RS (2008). Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 33: 88-109.
44. R-Development-Core-Team (2013): R: A language and environment for statistical computing. http://www.R-project.org/.
45. Rainer J Sanchez-Cabo F Stocker G Sturn A Trajanoski Z 2006 CARMAweb: Comprehensive R-and bioconductor-based web service for microarray data analysis. Nucleic Acids Res 34(Web Server issue) W498-W503.
46. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J et al (2011). Global quantification of mammalian gene expression control. Nature 473: 337-342.
47. Sharova LV, Sharov AA, Nedorezov T, Piao Y, Shaik N, Ko MS (2009). Data base for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells. DNA Res 16: 45-58.
48. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Redd y R, Aschner M, Lewis DA et al (2011). Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16: 751-762.
49. Sillaber I, Panhuysen M, Henniger MS, Ohl F, Kuhne C, Putz B et al (2008). Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl) 200: 557-572.
50. Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ et al (2012). Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2: E199.
51. Surget A, Tanti A, Leonardo ED, Laugeray A, Rainer Q, Touma C et al (2011). Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 16: 1177-1188.
52. Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G et al (2009). Corticolimbic transcriptome changes are statedependent and region-specific in a rodent model of depression and of antidep ressant reversal. Neuropsychopharmacology 34: 1363-1380.
53. Sweatt JD (2004). Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14: 311-317.
54. Taka hashi Y, Washiyama K, Kobayashi T, Hayashi S (2006). Gene expression in the brain from fluoxetine-injected mouse using DNA microarray. Ann NY Acad Sci 1074: 42-51.
55. Tanti A, Belzung C (2013). Ne urogenesis along the septo-temporal axis of the hippocampus: Are depression and the action of antidepressants region-specific? Neuroscience 252: 234-252.
56. Tardito D, Molteni R, Popoli M, Racagni G (2012). Synergistic mechanisms involved in the antidepressant effects of agomelatine. Eur Neuropsychopharmacol 22(Suppl 3): S482-S486.
57. Villanueva R (2013). Neur obiology of major depressive disorder. Neural Plast (Article ID 873278
58. Wainwright SR, Galea La (2013). The neural plasticity theory of depression: Assessing the roles of adult neurogenesis and PSANCAM within the hippocampus. Neural Plast (Article ID 805497
59. Willner P, Scheel-Kruger J, Belzung C (2013). The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 37(Pt 1): 2331-2371.